Kim M Gernert1, Sandra Seby1, Matthew W Schmerer1, Jesse C Thomas1, Cau D Pham1, Sancta St Cyr1, Karen Schlanger1, Hillard Weinstock1, William M Shafer1, Brian H Raphael1, Ellen N Kersh1. 1. Laboratory Reference and Research Branch (K M Gernert PhD, S Seby MS, M W Schmerer PhD, J C Thomas IV PhD, C D Pham PhD, B H Raphael PhD, E N Kersh PhD), Surveillance and Data Management Branch (S St Cyr MD, H Weinstock PhD), and Epidemiology and Statistics Branch (K Schlanger PhD), Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA; Oak Ridge Institute for Science and Education Research Participation and Fellowship Program, Oak Ridge, TN, USA (S Seby, J C Thomas IV); Department of Microbiology and Immunology and Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA, USA (W M Shafer PhD); and Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center, Decatur, GA, USA (W M Shafer).
Abstract
BACKGROUND: The number of cases of gonorrhoea in the USA and worldwide caused by Neisseria gonorrhoeae is increasing (555 608 reported US cases in 2017, and 87 million cases worldwide in 2016). Many countries report declining in vitro susceptibility of azithromycin, which is a concern because azithromycin and ceftriaxone are the recommended dual treatment in many countries. We aimed to identify strain types associated with decreased susceptibility to azithromycin. METHODS: We did a genomic analysis of N gonorrhoeae isolates obtained by the US Gonococcal Isolate Surveillance Project. Isolates were whole-genome sequenced based on decreased susceptibility to azithromycin (minimal inhibitory concentration [MIC] ≥2 μg/mL, using agar dilution antibiotic susceptibility testing) and geographical representation. Bioinformatic analyses established genomic diversity, strain population dynamics, and antimicrobial resistance profiles. FINDINGS: 410 isolates were sorted into more than 20 unique phylogenetic clades. One predominant persistent clade (consisting of 97 isolates) included the most isolates with azithromycin MICs of 2 μg/mL or higher (61 of 97 [63%] vs 59 of 311 [19%]; p<0·0001) and carried a mosaic mtr (multiple transferable resistance) locus (68 of 97 [70%] vs two of 313 [1%]; p<0·0001). Of the remaining 313 isolates, 57 (18%) had decreased susceptibility to azithromycin (MIC ≥4 μg/mL), which was attributed to 23S rRNA variants (56 of 57 [98%]) and formed phylogenetically diverse clades, showing various levels of clonal expansion. INTERPRETATION: Reduced azithromycin susceptibility was associated with expanding and persistent clades harbouring two well described resistance mechanisms, mosaic mtr locus and 23S rRNA variants. Understanding the role of recombination, particularly within the mtr locus, on the fitness and expansion of strains with decreased susceptibility has important implications for the public health response to minimise gonorrhoea transmission. FUNDING: US Centers for Disease Control and Prevention (CDC), CDC Combating Antibiotic Resistant Bacteria initiative, Oak Ridge Institute for Science Education, US Department of Energy/CDC/Emory University, National Institutes of Health, and Biomedical Laboratory Research and Development Service of the US Department of Veterans Affairs.
BACKGROUND: The number of cases of gonorrhoea in the USA and worldwide caused by Neisseria gonorrhoeae is increasing (555 608 reported US cases in 2017, and 87 million cases worldwide in 2016). Many countries report declining in vitro susceptibility of azithromycin, which is a concern because azithromycin and ceftriaxone are the recommended dual treatment in many countries. We aimed to identify strain types associated with decreased susceptibility to azithromycin. METHODS: We did a genomic analysis of N gonorrhoeae isolates obtained by the US Gonococcal Isolate Surveillance Project. Isolates were whole-genome sequenced based on decreased susceptibility to azithromycin (minimal inhibitory concentration [MIC] ≥2 μg/mL, using agar dilution antibiotic susceptibility testing) and geographical representation. Bioinformatic analyses established genomic diversity, strain population dynamics, and antimicrobial resistance profiles. FINDINGS: 410 isolates were sorted into more than 20 unique phylogenetic clades. One predominant persistent clade (consisting of 97 isolates) included the most isolates with azithromycin MICs of 2 μg/mL or higher (61 of 97 [63%] vs 59 of 311 [19%]; p<0·0001) and carried a mosaic mtr (multiple transferable resistance) locus (68 of 97 [70%] vs two of 313 [1%]; p<0·0001). Of the remaining 313 isolates, 57 (18%) had decreased susceptibility to azithromycin (MIC ≥4 μg/mL), which was attributed to 23S rRNA variants (56 of 57 [98%]) and formed phylogenetically diverse clades, showing various levels of clonal expansion. INTERPRETATION: Reduced azithromycin susceptibility was associated with expanding and persistent clades harbouring two well described resistance mechanisms, mosaic mtr locus and 23S rRNA variants. Understanding the role of recombination, particularly within the mtr locus, on the fitness and expansion of strains with decreased susceptibility has important implications for the public health response to minimise gonorrhoea transmission. FUNDING: US Centers for Disease Control and Prevention (CDC), CDC Combating Antibiotic Resistant Bacteria initiative, Oak Ridge Institute for Science Education, US Department of Energy/CDC/Emory University, National Institutes of Health, and Biomedical Laboratory Research and Development Service of the US Department of Veterans Affairs.
Authors: Susanne Jacobsson; Daniel Golparian; Michelle Cole; Gianfranco Spiteri; Irene Martin; Thea Bergheim; Maria José Borrego; Brendan Crowley; Tania Crucitti; Alje P Van Dam; Steen Hoffmann; Samo Jeverica; Peter Kohl; Beata Mlynarczyk-Bonikowska; Gatis Pakarna; Angelika Stary; Paola Stefanelli; Peter Pavlik; Eva Tzelepi; Raquel Abad; Simon R Harris; Magnus Unemo Journal: J Antimicrob Chemother Date: 2016-07-17 Impact factor: 5.790
Authors: Ellen N Kersh; Vanessa Allen; Eric Ransom; Matthew Schmerer; Sancta Cyr; Kim Workowski; Hillard Weinstock; Jean Patel; Mary Jane Ferraro Journal: Clin Infect Dis Date: 2020-02-14 Impact factor: 9.079
Authors: Ellen N Kersh; Cau D Pham; John R Papp; Robert Myers; Richard Steece; Grace Kubin; Romesh Gautom; Evelyn E Nash; Samera Sharpe; Kim M Gernert; Matthew Schmerer; Brian H Raphael; Tara Henning; Anne M Gaynor; Olusegun Soge; Karen Schlanger; Robert D Kirkcaldy; Sancta B St Cyr; Elizabeth A Torrone; Kyle Bernstein; Hillard Weinstock Journal: J Clin Microbiol Date: 2020-03-25 Impact factor: 5.948
Authors: Jesse C Thomas; Sandra Seby; A Jeanine Abrams; Jack Cartee; Sean Lucking; Eshaw Vidyaprakash; Matthew Schmerer; Cau D Pham; Jaeyoung Hong; Elizabeth Torrone; Sancta St Cyr; William M Shafer; Kyle Bernstein; Ellen N Kersh; Kim M Gernert Journal: J Infect Dis Date: 2019-06-19 Impact factor: 5.226
Authors: I Martin; P Sawatzky; V Allen; B Lefebvre; Lmn Hoang; P Naidu; J Minion; P Van Caeseele; D Haldane; R R Gad; G Zahariadis; A Corriveau; G German; K Tomas; M R Mulvey Journal: Can Commun Dis Rep Date: 2019-02-07
Authors: David W Eyre; Nicholas D Sanderson; Emily Lord; Natasha Regisford-Reimmer; Kevin Chau; Leanne Barker; Markus Morgan; Robert Newnham; Daniel Golparian; Magnus Unemo; Derrick W Crook; Tim Ea Peto; Gwenda Hughes; Michelle J Cole; Helen Fifer; Anne Edwards; Monique I Andersson Journal: Euro Surveill Date: 2018-07
Authors: Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor Journal: Bull World Health Organ Date: 2019-06-06 Impact factor: 9.408
Authors: Sandeep J Joseph; Jesse C Thomas; Matthew W Schmerer; John C Cartee; Sancta St Cyr; Karen Schlanger; Ellen N Kersh; Brian H Raphael; Kim M Gernert Journal: Genome Biol Evol Date: 2022-01-04 Impact factor: 3.416
Authors: John C Cartee; Sandeep J Joseph; Emily Weston; Cau D Pham; Jesse C Thomas; Karen Schlanger; Sancta B St Cyr; Monica M Farley; Ashley E Moore; Amy K Tunali; Charletta Cloud; Brian H Raphael Journal: Open Forum Infect Dis Date: 2022-05-13 Impact factor: 4.423
Authors: Grace A Beggs; Julio C Ayala; Logan G Kavanaugh; Timothy D Read; Grace M Hooks; Maria A Schumacher; William M Shafer; Richard G Brennan Journal: Nucleic Acids Res Date: 2021-04-19 Impact factor: 16.971
Authors: Leonor Sánchez-Busó; Corin A Yeats; Benjamin Taylor; Richard J Goater; Anthony Underwood; Khalil Abudahab; Silvia Argimón; Kevin C Ma; Tatum D Mortimer; Daniel Golparian; Michelle J Cole; Yonatan H Grad; Irene Martin; Brian H Raphael; William M Shafer; Katy Town; Teodora Wi; Simon R Harris; Magnus Unemo; David M Aanensen Journal: Genome Med Date: 2021-04-19 Impact factor: 11.117
Authors: Sancta St Cyr; Lindley Barbee; Kimberly A Workowski; Laura H Bachmann; Cau Pham; Karen Schlanger; Elizabeth Torrone; Hillard Weinstock; Ellen N Kersh; Phoebe Thorpe Journal: MMWR Morb Mortal Wkly Rep Date: 2020-12-18 Impact factor: 17.586
Authors: Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Chad S Hewitt; Ahmed Elkashif; Bruce R Cooper; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty Journal: J Enzyme Inhib Med Chem Date: 2022-12 Impact factor: 5.051
Authors: Nicole H T M Dukers-Muijrers; Ymke J Evers; Christian J P A Hoebe; Petra F G Wolffs; Henry J C de Vries; Bernice Hoenderboom; Marianne A B van der Sande; Janneke Heijne; Jeffrey D Klausner; Jane S Hocking; Jan van Bergen Journal: BMC Infect Dis Date: 2022-03-14 Impact factor: 3.090
Authors: Kevin C Ma; Tatum D Mortimer; Marissa A Duckett; Allison L Hicks; Nicole E Wheeler; Leonor Sánchez-Busó; Yonatan H Grad Journal: Nat Commun Date: 2020-10-23 Impact factor: 14.919